ACXIT Capital Partners
A Stifel Company
About
ACXIT is a leading international corporate finance and financial advisory firm for mid-market clients and entrepreneurs in Europe and beyond. Our clients are corporations, family-owned businesses, entrepreneurs, financial sponsors and family offices.
Since July 2022, we are part of global full-service investment bank Stifel. For more information, please visit Stifel Europe’s website.
Services
Since 1999, we offer our clients comprehensive corporate finance advisory services including M&A and capital markets advisory as well as restructuring, debt and strategic advisory. To date, we have completed nearly 500 transactions with a total deal/financing volume of more than EUR 24bn, many of them acknowledged and honored by our industry peers – and most importantly by our clients. While our home market is in the German speaking region, most clients are international and transactions cross-border.
Industries
Our advisory expertise is founded on an in-depth understanding of the key industries served by our company, covering both the industrial and technology sectors. We have successfully advised clients in Internet & Media, Software & IT, Mobility, Mobile & Telecom, Healthcare & Pharma, Retail & Consumer Goods, Real Estate and General Industries.
ACXIT ADVISED THE SHAREHOLDERS OF GERMAN ANALYTICAL CRO BIOASSAY GMBH ON THE SALE TO REACTION BIOLOGY CORP.
Frankfurt am Main, 08 December 2022: ACXIT – A Stifel Company acted as exclusive sellside advisor to the shareholders of Bioassay Labor für biologische Analytik GmbH (“Bioassay”), including its wholly-owned subsidiary, Peptide Specialty Laboratories GmbH (“PSL”), located in Heidelberg/Germany, on the sale of the company to Reaction Biology Corp., based in Malvern, PA.
This deal adds another reference transaction to ACXIT’s strong track record in the Healthcare and Life Sciences sector and positions the group well to serve its corporate customers as well as financial sponsors on transactions in the fast growing Pharma Services market, including analytical CRO and CDMO markets.
News Archive
Highlight Transactions